tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering
PremiumThe FlyXortx Therapeutics prices 1.75M shares at 63c in registered direct offering
12d ago
XORTX Receives Nasdaq Extension for Compliance
Premium
Company Announcements
XORTX Receives Nasdaq Extension for Compliance
12d ago
XORTX Acquires Renal Anti-Fibrotic Program to Advance Kidney Disease Treatments
Premium
Company Announcements
XORTX Acquires Renal Anti-Fibrotic Program to Advance Kidney Disease Treatments
16d ago
Xortx Therapeutics initiates IND preparation for XORLO in gout program
PremiumThe FlyXortx Therapeutics initiates IND preparation for XORLO in gout program
2M ago
XORTX Therapeutics Reports Financial Results for Mid-2025
Premium
Company Announcements
XORTX Therapeutics Reports Financial Results for Mid-2025
3M ago
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs
Premium
Company Announcements
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs
3M ago
XORTX Therapeutics Completes US$925,000 Private Placement to Fund Gout Programs
PremiumCompany AnnouncementsXORTX Therapeutics Completes US$925,000 Private Placement to Fund Gout Programs
3M ago
XORTX Therapeutics Announces $925,000 Private Placement to Advance Gout Programs
Premium
Company Announcements
XORTX Therapeutics Announces $925,000 Private Placement to Advance Gout Programs
4M ago
XORTX Therapeutics Announces $3 Million Offering to Advance Gout Programs
Premium
Company Announcements
XORTX Therapeutics Announces $3 Million Offering to Advance Gout Programs
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100